Tag Archives: Levodopa/therapeutic use

Progression of monoaminergic dysfunction in Parkinson’s disease: a longitudinal 18F-dopa PET study

Pavese N, Rivero-Bosch M, Lewis SJ, Whone AL, Brooks DJ. Progression of monoaminergic dysfunction in Parkinson’s disease: a longitudinal 18F-dopa PET study. Neuroimage. June 2011;56(3):1463-1468. Publication Date June 2011 How Analyze was Used “The standard object map was applied to the spatially normalised K i maps and the values for specific 18F-dopa uptake in individual…

A technique for standardized central analysis of 6-(18)F-fluoro-L-DOPA PET data from a multicenter study

Whone AL, Bailey DL, Remy P, Pavese N, Brooks DJ. A technique for standardized central analysis of 6-(18)F-fluoro-L-DOPA PET data from a multicenter study. J Nucl Med. July 2004;45(7):1135-1145. Full Text – Open Access Publication Date July 2004 How Analyze was Used “The next check was an interactive visual assessment of the appearance of each…

Isolated tremor and disruption of the nigrostriatal dopaminergic system: an 18F-dopa PET study

Brooks DJ, Playford ED, Ibanez V, Sawle GV, Thompson PD, Findley LJ, Marsden CD. Isolated tremor and disruption of the nigrostriatal dopaminergic system: an 18F-dopa PET study. Neurology. August 1992;42(8):1554-1560. Publication Date August 1992 How Analyze was Used “Region of interest (ROI) analysis was performed on SUN 3/60 workstations using image analysis software (ANALYZE 3.0).”…